Catalent's (CTLT) Latest Partnership to Boost Clinical Trials

The latest partnership is expected to be a significant stepping stone for its Biologics business and solidify its foothold in the niche space. Rational Behind the Collaboration Under the partnership, Catalent will provide process development and cGMP (current good manufacturing practices) manufacturing of Siren Biotechnology's AAV vector-based therapeutic candidates for use in clinical trials. Catalent will also support process optimization at its process and clinical development center in Baltimore, MD. Pe ...